01 Oct 2020 – Destiny Pharma welcomes proposed PASTEUR Act in USA

Destiny Pharma welcomes the proposed PASTEUR Act in USA, with financial support ranging from $750 million to $3 billion, to launch new antiinfective products targeting life threatening infections.

Click on the link below for more information:-

PASTEUR Act – 30 September 2020